GlassScriptPhysician profile
Steven Ray Lenga
NPI 1669473633
$18,934.18
in general payments reported to CMS, 2019-2025
53 companies · $2,982 in 2025
The $2,982 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,893 · 2020: $2,063 · 2021: $3,200 · 2022: $2,952 · 2023: $2,664 · 2024: $3,180 · 2025: $2,982.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,827.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,826.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $4,121.94 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,719.14 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $1,692.92 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Amgen INC. | $1,376.39 | 2019-2025 | Evenity, Prolia, Repatha |
| Abbvie INC. | $1,066.41 | 2021-2025 | |
| Pfizer INC. | $1,062.08 | 2019-2025 | |
| Amarin Pharma, INC. | $978.54 | 2019-2023 | |
| Astellas Pharma US INC | $962.34 | 2019-2025 | Veozah, Myrbetriq |
| Janssen Pharmaceuticals, INC | $629.58 | 2019-2025 | Spravato |
| Glaxosmithkline, LLC. | $561.40 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $392.42 | 2021-2025 | Jardiance |
| Dexcom, INC. | $376.34 | 2022-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $353.50 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $299.74 | 2019-2025 | Trintellix |
| Esperion Therapeutics, INC. | $247.03 | 2021-2025 | Nexletol |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $189.96 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $187.12 | 2019-2025 | Xifaxan, Trulance |
| Idorsia Pharmaceuticals US INC | $170.76 | 2023 | Quviviq |
| Allergan, INC. | $164.74 | 2019-2020 | |
| Abbott Laboratories | $161.42 | 2021-2025 | Freestyle Libre 3 |
| Si-Bone, INC. | $158.70 | 2022 | |
| Sanofi-Aventis U.S. LLC | $155.60 | 2019-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $151.20 | 2022 | |
| Recor Medical INC | $144.88 | 2025 | Paradise Ultrasound Renal Denervation System |
| Sumitomo Pharma America, INC. | $144.14 | 2023-2025 | Gemtesa |
| Sanofi Pasteur INC. | $122.35 | 2019-2025 | |
| Xeris Pharmaceuticals, INC. | $109.95 | 2024-2025 | Gvoke Hypopen |
| Medtronic USA, INC. | $107.45 | 2019 | |
| Novartis Pharmaceuticals Corporation | $105.31 | 2019-2025 | |
| Biohaven Pharmaceuticals, INC. | $80.13 | 2021 | |
| Nestle Healthcare Nutrition INC. | $79.52 | 2022-2023 | |
| Avanir Pharmaceuticals, INC. | $76.31 | 2019 | |
| Currax Pharmaceuticals LLC | $71.09 | 2022-2023 | Contrave, Nexletol, Nexlizet |
| Eisai INC. | $68.13 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $67.24 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $63.71 | 2019-2021 | |
| Kyowa Kirin, INC. | $51.73 | 2020-2021 | |
| Otsuka America Pharmaceutical, INC. | $45.71 | 2023-2025 | Rexulti |
| Edwards Lifesciences Corporation | $45.39 | 2024-2025 | |
| Sunovion Pharmaceuticals INC. | $42.62 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $40.56 | 2023-2024 | Eliquis |
| Boston Scientific Corporation | $39.83 | 2022-2023 | Watchman Access System |
| Nevro Corp. | $36.09 | 2022 | |
| Ethicon INC. | $34.43 | 2020 | |
| Genentech USA, INC. | $33.20 | 2019-2022 | |
| Insmed, INC. | $27.32 | 2025 | Arikayce |
| Biogen, INC. | $26.05 | 2021 | |
| Neuronetics, INC. | $20.77 | 2025 | Neurostar Tms Therapy System |
| Corcept Therapeutics | $15.05 | 2025 | Korlym |
| Teva Pharmaceuticals USA, INC. | $14.48 | 2023 | Austedo Xr |
| Arbor Pharmaceuticals, INC. | $14.43 | 2019 | |
| Radius Health, INC. | $14.26 | 2021 | |
| Cardiovascular Systems INC. | $12.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Lenga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.